Steven Cohen's position in Cytokinetics is currently worth $10.2 Million. That's 0.03% of their equity portfolio (527th largest holding). The first Cytokinetics trade was made in Q2 2019. Since then Steven Cohen bought shares eight more times and sold shares on ten occasions. The stake costed the investor $5.69 Million, netting the investor a gain of 79% so far.